Break it Down: Orthocell appoints first Canadian distributor for Remplir

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Tylah Tully unpacks the latest news from Orthocell (ASX:OCC), who has appointed its first Canadian distributor for Remplir, as it pushes ahead with commercialisation in the US$75 million dollar Canadian nerve repair market.

The initial distribution deal covers Alberta and British Columbia, but Orthocell has plans for further distributors expected to extend access across all of Canada. 

Watch the video for more.

 

While Orthocell is a Stockhead advertiser, it did not sponsor this content.

Related Topics

Explore more

Explore more

Investor Guide: Health & Biotech FY2025 featuring Tim Boreham

Read The Guide